Creative Biogene Helps CGT Catch Up To The Flash

The Creative Biogene DNA

With cutting-edge technologies, Creative Biogene is committed to assisting researchers in making significant advances. The broad range of reagents, tools, and services supports developments in the biomedical research, including therapeutic interventions with front diagnostics. CAR-T therapy, immune phenotyping, genetic testing, cell and gene therapy, communicable diseases investigations, vaccine development, medicinal chemistry, antibiotic-resistance monitoring, and oncology research are just a few of the many applications Creative Biogene can support thanks to its skilled scientific staff.

Creative Biogene has announced the launch of their GMP lentivirus production service to quicken research into cell therapy and gene therapy.

Proven Viral Vector Expertise

With over 100 viral and cell bank production projects completed and tested in accordance with GMP standards, Creative Biogene has over a decade of experience producing viral vectors. From small-scale prototype during the early stages of research to large-scale manufacturing up to 2,000 L, the one-stop GMP production plant can meet a variety of manufacturing demands.

Lentivirus, adenovirus, and adeno-associated virus (AAV) are just a few of the viral vectors that Creative Biogene aids clients with the GMP manufacture of, with an emphasis on optimizing the platform procedure and expediting the translation to the clinic. Creative Biogene can offer the most cost-effective and superior GMP grade viral services because of its years of expertise in the manufacturing, purification, and profiling of viral products.

The manufacture, purification, and characterization of clinical-grade lentiviruses for gene therapy in accordance with GMP standards requires integrated process technology. In order to guarantee clinical product quality, safety, and consistency for gene therapy clinical trials, Creative Biogene, a leader in lentiviral production, combines cutting-edge lentiviral production technology with developed systematic GMP program controls. A proprietary, incredibly effective technology for producing ultra-high titer lentiviral vectors, including at clinical size, has been created by Creative Biogene.

Specialized, State-of-the-Art, Scaled Up!

In addition to providing QA and QC groups to oversee the documentation needed from equipment validation to authorization of GMP products (validation reports, SOPs, batch records, and so forth) of the entire production process, Creative Biogene has designed three distinct state-of-the-art GMP facilities dedicated exclusively to microbiology, cell culture, and virus production.

The major goal of Creative Biogene, according to Marketing Director Marcia Brady, is to create top-notch, cutting-edge tools and services that will hasten discovery. Brady claims that the business’s customized virus services provide virus counts with consistently high titers and high quantities to help with all aspects of viral vector creation and development.

About Creative Biogene

Offering cutting-edge technologies, products, one-of-a-kind tools, and services for research discoveries and product development, Creative Biogene is a leading firm of its kind dedicated to advancing human science through biotechnology. With more than ten years of expertise and internal specialists, Creative Biogene has established itself as a market leader to assist researchers all over the world.

Engr. Dex Marco Tiu Guibelondo, BS Pharm, RPh, BS CpE

Editor-in-Chief, PharmaFEATURES